0001209191-23-049781.txt : 20230918
0001209191-23-049781.hdr.sgml : 20230918
20230918170712
ACCESSION NUMBER: 0001209191-23-049781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230918
DATE AS OF CHANGE: 20230918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Emany Sravan Kumar
CENTRAL INDEX KEY: 0001897662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 231261810
MAIL ADDRESS:
STREET 1: 100 SUMMER ST
STREET 2: SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-15
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001897662
Emany Sravan Kumar
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
0
1
0
0
SVP, Chief Financial Officer
0
Class A Common Stock
2023-09-15
4
P
0
36072
8.32
A
188730
D
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.31 to $8.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Brian Tessler, Attorney-in-Fact
2023-09-18